Is Jamie Dimon the Banking Crisis’s Big Winner, and the Pharma Stock Hitting One Record After Another 5/1/23
CNBC's "Fast Money"
00:00
What Is Driving Monjaro's Uptake?
I think at least 10% upside when Eli Lilly shows Zamas data in first half of the year. That could just be upside to the stock that's not factored in at this point. Other agent Wigovi has improved its supply and so did Monjaro as well. So I would say it is pretty much demand driven right now.
Play episode from 32:46
Transcript
